Warning: The NCBI web site requires JavaScript to function. more...
A functional Notch-survivin gene signature in basal breast cancer.
Lee CW, Simin K, Liu Q, Plescia J, Guha M, Khan A, Hsieh CC, Altieri DC.
Breast Cancer Res. 2008;10(6):R97. Epub 2008 Nov 24.
Related citations
Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.
Lee CW, Raskett CM, Prudovsky I, Altieri DC.
Cancer Res. 2008 Jul 1;68(13):5273-81.
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
Clin Cancer Res. 2006 Jan 1;12(1):11-9.
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Yau C, Benz CC.
Breast Cancer Res. 2008;10(4):R61. Epub 2008 Jul 17.
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR.
PLoS One. 2009 Jul 3;4(7):e6146.
Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
Nassar A, Lawson D, Cotsonis G, Cohen C.
Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):113-20.
A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.
Breast Cancer Res. 2008;10(5):R88. Epub 2008 Oct 17.
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.
Smalley MJ, Iravani M, Leao M, Grigoriadis A, Kendrick H, Dexter T, Fenwick K, Regan JL, Britt K, McDonald S, Lord CJ, Mackay A, Ashworth A.
Breast Cancer Res. 2007;9(6):R85.
[Isolation of CD44+/CD24 -/low and side population cells from MDA-MB-453 cells and the analysis of their activation of Wnt and Notch pathway].
Li X, Ren J.
Beijing Da Xue Xue Bao. 2008 Oct 18;40(5):471-5. Chinese.
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.
Breast Cancer Res. 2009;11(1):R1. Epub 2009 Jan 5.
Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ.
PLoS One. 2009;4(3):e4710. Epub 2009 Mar 9.
Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin.
Pizzoferrato E, Liu Y, Gambotto A, Armstrong MJ, Stang MT, Gooding WE, Alber SM, Shand SH, Watkins SC, Storkus WJ, Yim JH.
Cancer Res. 2004 Nov 15;64(22):8381-8.
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.
Breast Cancer Res. 2006;8(5):R56.
JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.
Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O'Malley FP, Egan SE, Andrulis IL.
Breast Cancer Res Treat. 2008 Oct;111(3):439-48. Epub 2007 Nov 8.
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.
Marty B, Maire V, Gravier E, Rigaill G, Vincent-Salomon A, Kappler M, Lebigot I, Djelti F, Tourdès A, Gestraud P, Hupé P, Barillot E, Cruzalegui F, Tucker GC, Stern MH, Thiery JP, Hickman JA, Dubois T.
Breast Cancer Res. 2008;10(6):R101. Epub 2008 Dec 3.
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA.
Breast Cancer Res. 2008;10(5):R85. Epub 2008 Oct 15. Erratum in: Breast Cancer Res. 2009;11(1):401.
Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome.
Umemura S, Shirane M, Takekoshi S, Kusakabe T, Itoh J, Egashira N, Tokuda Y, Mori K, Osamura YR.
Br J Cancer. 2009 Mar 10;100(5):764-71.
Immunohistochemical analysis of survivin expression in primary breast cancers.
Chu JS, Shew JY, Huang CS.
J Formos Med Assoc. 2004 Dec;103(12):925-31.
Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway.
Croci DO, Cogno IS, Vittar NB, Salvatierra E, Trajtenberg F, Podhajcer OL, Osinaga E, Rabinovich GA, Rivarola VA.
J Cell Biochem. 2008 Oct 1;105(2):381-90.
Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
Du Z, Li J, Wang L, Bian C, Wang Q, Liao L, Dou X, Bian X, Zhao RC.
Cancer Sci. 2010 Nov;101(11):2417-24. doi: 10.1111/j.1349-7006.2010.01700.x.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on